Inclusion Criteria:  Both males and females Five years duration of clinically diagnosed type 2 Diabetes were included in the study On insulin therapy Diagnosed to have peripheral neuropathy according to Michigan Neuropathy Screening Instrument with a physical examination score > 2.5  Exclusion Criteria:  Type 1 Diabetics Type 2 Diabetics On oral hypoglycemic and Glucagon-like Peptide-1 analogues, patients having neuropathies due to other causes (Vitamin B₁₂ deficiency, Drug and Alcohol abuse), patients with other co-morbidities (Renal insufficiency, Heart, Liver and Eye diseases) Patients with foot ulcers and orthopedic or surgical problems of lower limb Patients with peripheral vascular diseases, inability to walk independently Patients receiving any structured supervised physiotherapy intervention Pregnant females were excluded from the study